Nuvectis Pharma
NVCT
NVCT
11 hedge funds and large institutions have $7.38M invested in Nuvectis Pharma in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $10M → $7.38M (-$2.67M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
11
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.27M | |
| 2 | +$93K | |
| 3 | +$2.25K | |
| 4 |
Morgan Stanley
New York
|
+$750 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$90 |
Top Sellers
| 1 | -$341K | |
| 2 | -$28.8K | |
| 3 | -$19.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |